Beth Hecht
CIK 1652410 · See Remarks · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.65M
Companies
4
Total Filings
48
Lifetime Open-Market Net
-$1.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | See Remarks | 1,144,462 | $8.43 | $9.65M | -$1.33M | 29 | 2026-08-04 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 18,839 | $0.03 | $565 | $0 | 6 | 2023-06-15 |
| AYTU | Director | 453 | $2.25 | $1.0K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | 0 | $1.15 | $0 | $0 | 7 | 2021-03-19 |
Recent Filings · Page 2 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-02 | XERS | Sell (S) | −16,667 | -$116.8K | EDGAR |
| 2025-11-13 | XERS | Sell (S) | −16,667 | -$123.3K | EDGAR |
| 2025-11-12 | XERS | Notice (144) | −66,668 | -$514.7K | EDGAR |
| 2025-03-21 | XERS | Sell (S) | −40,000 | -$217.2K | EDGAR |
| 2025-03-20 | XERS | Notice (144) | −40,000 | -$205.6K | EDGAR |
| 2025-02-03 | XERS | Mixed | +40,716 | -$513.7K | EDGAR |
| 2025-01-07 | XERS | Tax (F) | −32,039 | -$115.7K | EDGAR |
| 2024-08-09 | XERS | Tax (F) | −178,006 | -$350.6K | EDGAR |
| 2024-01-31 | XERS | Grant (A) | +750,000 | $0 | EDGAR |
| 2023-06-15 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +15,853 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.